Our latest press releases, media appearances and news commentary.
The UK Government has announced a £55m five-year investment in Medicines Discovery Catapult.
Medicines Discovery Catapult and AstraZeneca collaborate to unlock the potential of Acoustic Mist Ionisation Mass Spectrometry.
OptibriumTM, Intellegens and Medicines Discovery Catapult awarded funding to apply machine learning in drug discovery.
Our Head of Molecular Technologies, Dr Martin Main, has been invited to serve as a member of the SLAS Discovery Editorial Board.
Innovate UK, as part of UK Research and Innovation, is looking to support female rising stars in business innovation.
Medicines Discovery Catapult has appointed Dr Robin Brown as its new Chairman.
CEO, Chris Molloy, was awarded Membership of the Institute of Cancer Research (ICR) at a ceremony in London.
CBSO, Mark Samuels, had a Letter to the Editor published in The Times.
Health Secretary Matt Hancock officially opened the biggest diagnostic lab network in British history.
CEO, Chris Molloy, discusses the role of Medicines Discovery Catapult within the UK as a centre for applied medical R&D.
See how we can help support you with your next drug discovery project.
Speak to us